Pediatric and Adolescent Obesity Treatment: Since FDA approval in 2022, GLP-1 receptor agonists have been prescribed for individuals aged 12 years and older with obesity (BMI 95th percentile)
For example, the gut-brain connection identifies imbalances in gut bacteria or inflammation that can directly affect mood, behavior and cognition
These lesions can therefore be mistaken clinically for a scar, a fibroma, basal cell and squamous cell carcinomas, or fibromatosis, delaying their correct diagnosis and treatment
However, as with any medical weight loss program, results can vary depending on individual health factors, adherence to treatment, and lifestyle changes
Supplementation with serine and an NAD + precursor, like tryptophan, niacin, or nicotinamide riboside (NR), along with NAC are expected to increase NAD+, glutathione, and fat oxidation in the liver, leading to lower levels of oxidative stress, resulting in lower hepatic steatosis and its progression